Eurofins Scientific Purchases 27% of GeneScan Europe AG
The reflection over this take-over has been facilitated, after the management of GeneScan has proposed a full restructuring of the overall business activities one month ago. This restructuring puts the focus on the GMO and chip based analysis service business. Therefore, the company fits well with the business portfolio of the Eurofins Group. While the restructuring costs and payment of GeneScan's contractual obligations will - according to a GeneScan press release of January 8, 2003 - consume the larger part of GeneScan's cash reserves, the management is confident that this refocusing can be achieved as planned and lead to a viable business.
Eurofins believes, that the take-over will enhance the chances of success of the planned turn-around of GeneScan, due to synergies that may result of a complete integration into the Eurofins Group. Eurofins' experience of restructuring situations, its international network of laboratories, its complete portfolio of assays as well as the commitment of the management of GeneScan may indeed facilitate a fast and drastic cost reduction and a concerted international sales effort, required for a successful turn-around.
After the restructuring, in order for the business to be more cost effective in a highly competitive market, it is planned that GeneScan's four sites will be integrated as a GMO testing business unit into Eurofins' worldwide network of around 50 laboratories, so as to benefit from the Group's cross-selling possibilities. Furthermore, the reduced and refocused biochip service business of GeneScan will supplement Eurofins' portfolio in diagnostics and toxicology. Following a successful completion of the offer it is planned to review the possibility of a delisting of the GeneScan shares from the Frankfurt stock exchange.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.